Drug Type Universal CAR-T |
Synonyms |
Target- |
Mechanism Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Smart Immune SASStartup |
Active Organization- |
Inactive Organization Smart Immune SASStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | FR | Smart Immune SASStartup | 18 Mar 2022 |